:quality(85):extract_cover()/2024/09/19/768/n/49351082/tmp_kfDUx8_8844982382f654b3_SHOT-11-GLP-72-0.JPEG)
Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Management of MASLD with CKD should involve a multidisciplinary approach, including hepatologists, nephrologists, endocrinologists, and primary care physicians
Giacco A, Delli Paoli G, Senese R, Cioffi F, Silvestri E, Moreno M, et al
SGLT2 inhibitors (such as empagliflozin, dapagliflozin, or canagliflozin) are particularly recommended for patients with established cardiovascular disease, heart failure, or chronic kidney disease
2009 Aagaard NK et al
Your Feedback What do you think
US$ 24.42
US$ 20.41
US$ 25.10
